论文信息 - Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct‐Acting Antiviral Agents - 字舞流文

Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct‐Acting Antiviral Agents

Andrew A. Li | Z. Younossi | G. Cholankeril | Donghee Kim | Aijaz Ahmed | E. Yoo | S. Gonzalez | K. March | Heather S Snyder

[1] M. Berenguer,et al. The New Era of Hepatitis C: Therapy in Liver Transplant Recipients. , 2017, Clinics in liver disease.

[2] Aasld Idsa Hcv Guidance Panel. Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus , 2015, Hepatology.

[3] Oscar J L Mitchell,et al. Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review , 2015, Journal of clinical and translational hepatology.

[4] R. Fontana,et al. Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation , 2015, Hepatology.

[5] X. Forns,et al. An interferon-free antiviral regimen for HCV after liver transplantation. , 2014, The New England journal of medicine.

[6] N. Selzner,et al. Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients. , 2011, Journal of hepatology.

[7] M. Salcedo Plaza. [Recurrence of hepatitis C after liver transplantation]. , 2000, Gastroenterologia y hepatologia.